Developing new economic models to incentivise antibiotic discovery and development activities while safeguarding the efficacy of antibiotics by researching and advocating their appropriate use.
DRIVE-AB Survey on Global Incidence of 4 Drug-Resistant Organisms is Now Available
A DRIVE-AB survey to gather information on the global incidence of infections caused by selected antibiotic-resistant bacteria is...
DRIVE-AB Partner Céline Pulcini Receives ESCMID Young Investigator Award
DRIVE-AB congratulates Work Package 1A partner Céline Pulcini on receiving the prestigious European...
DRIVE-AB Partner Otto Cars to serve as Expert in UN Inter-Agency Coordination Group on AMR
DRIVE-AB partner Prof Otto Cars, Uppsala University, has been formally nominated by the United Nations (UN) Secretary General...
DRIVE-AB Contributes to WHO New Priority Pathogen List
The World Health Organization (WHO), with some assistance from DRIVE-AB,...
Boston Consulting Group Publishes Follow-up Report for GUARD Initiative
The Boston Consulting Group (BCG) has published a follow-up report for the German Global Union for Antibiotics...